SWHR congratulates the Congress and the President for approving the Food and Drug Administration (FDA) Reauthorization Act of 2017. By providing significant funding and important improvements to FDA’s medical products review and approval process, this law will enable timely access to safe and effective medical innovations to millions of patients who need them.
BlogOn Wednesday, April 26, the U.S. House of Representatives passed the Limit, Save, Grow Act of 2023. These cuts could have serious implications for non-defense discretionary funding – and namely to health care and health research funding.
BlogCongress passed a short-term continuing resolution (CR) to keep the government funded at current levels through December 16, 2022, providing lawmakers more time to reach a deal on fiscal year (FY) 2023 spending legislation.
EventIn this virtual conference series, the Women’s Health Research Cluster will be hosting bi-weekly events including two keynote talks, four […]
EventIn this virtual conference series, the Women’s Health Research Cluster will be hosting bi-weekly events including two keynote talks, four […]
EventIn this virtual conference series, the Women’s Health Research Cluster will be hosting bi-weekly events including two keynote talks, four […]
EventIn this virtual conference series, the Women’s Health Research Cluster will be hosting bi-weekly events including two keynote talks, four […]
EventIn this virtual conference series, the Women’s Health Research Cluster will be hosting bi-weekly events including two keynote talks, four […]
EventIn this virtual conference series, the Women’s Health Research Cluster will be hosting bi-weekly events including two keynote talks, four […]
EventHosted by Virginia Commonwealth University, Health of Women 2022 was designed with a valued approach of addressing women’s health across […]